Day: June 20, 2023

CEO Greg Marken to meet with institutional investors GREENWOOD VILLAGE, Colo., June 20, 2023 (GLOBE NEWSWIRE) — Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the “Company” or “ADES”), a leader in emissions control solutions for power generation, industrial and municipal water purification markets, today announced that it will attend Roth’s 9th Annual London Conference June 21 – 22, 2023 in London. The Company’s Chief Executive Officer, Greg Marken, and members of management, will be participating in one-on-one and group meetings with institutional investors, analysts, family offices and high net-worth investors. About Advanced Emissions Solutions, Inc.Advanced Emissions Solutions, Inc. serves as the holding entity for a family of companies that provide environmental solutions to customers in the...

Confirming multi-year prior engagement and several proposals sent since January 2021 Proposed combination positioned to deliver at least $100M of cost synergies, previously identified by members of both companies’ management teams ROCK HILL, S.C., June 20, 2023 (GLOBE NEWSWIRE) — Today, 3D Systems (NYSE: DDD) (“3D Systems,” the “Company”) issued its response to Stratasys Ltd.’s (NASDAQ: SSYS) (“Stratasys”) determination that 3D Systems’ May 30, 2023 business combination proposal does not constitute a “Superior Proposal” pursuant to the terms of its existing merger agreement with Desktop Metal, Inc. (“Desktop Metal”). The Company is commenting now in order to update its shareholders and correct the record on certain assertations made by Stratasys this morning. President and CEO Dr. Jeffrey Graves stated, “We are disappointed that...

VYVGART Hytrulo Bottle VYVGART Hytrulo BottleVYVGART Hytrulo Logo VYVGART Hytrulo LogoTim Van Hauwermeiren argenx CEO, Tim Van Hauewermeirenargenx argenxVYVGART®Hytrulo is first FDA–approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG)With this approval, argenx broadens innovative gMG product offering and demonstrates continued commitment to providing more choice and flexibility for patientsEfficacy of VYVGART Hytrulo was established by demonstrating a comparable pharmacodynamic (PD) effect to VYVGART® in Phase 3 ADAPT-SC bridging studyManagement to host conference call tomorrow at 2:30pm CET (8:30 am ET)Regulated Information/Inside Information Amsterdam, the Netherlands—June 20, 2023—argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives...

COLUMBUS, Ohio, June 20, 2023 (GLOBE NEWSWIRE) — Worthington Industries, Inc. (NYSE: WOR) announced today that the D.C. Circuit Court of Appeals supported Worthington’s position in concluding that the U.S. Environmental Protection Agency’s (EPA) 2021 ban of non-refillable refrigerant cylinders is invalid because the EPA overstepped its authority granted by Congress. “We applaud the D.C. Circuit’s decision, which ensures that Worthington can continue to provide American-made, reliable, safe and affordable cylinders that are critical to the domestic refrigeration industry, while recognizing EPA’s authority to advance our shared goal of phasing out certain potent greenhouse gases under the American Innovation and Manufacturing (AIM) Act,” said Worthington Industries President & CEO Andy Rose. “We encourage EPA to accept the decision...

BOUCHERVILLE, Quebec, June 20, 2023 (GLOBE NEWSWIRE) — GROUPE LSL PHARMA INC (TSXV: LSL) – Groupe LSL Pharma Inc. (“the Company” or ” LSL Pharma Group “), a Canadian integrated pharmaceutical company, is pleased to announce that its total annual production capacity will be increased by approximately 35% to 40% as early as 2023, and further for 2024 and 2025, with its new facility in La Pocatière and a series of manufacturing optimizations in Upton. The Company would also like to point out that its Management’s Discussion and Analysis and its unaudited consolidated financial statements for the first quarter ended March 31, 2023 were filed on SEDAR on May 30, 2023. “The first quarter of 2023 was a period of transformation for LSL Pharma Group, as we began trading as a publicly traded company...

Ethan Allen’s Daydreamer Modular Sectional The modular Daydreamer sectional offers endless customization and configuration options.Ethan Allen Day Celebration Ethan Allen is proud to honor the pioneering spirit of its namesake and celebrate its legacy as a proud American brand.DANBURY, Conn., June 20, 2023 (GLOBE NEWSWIRE) — On June 23, Ethan Allen will hold its 7th annual Ethan Allen Day celebration at the company’s headquarters in Danbury, in addition to local events at Design Centers and manufacturing plants around North America. “We’ve celebrated this important milestone since 2016, when the state of Vermont declared June 23 to be Ethan Allen Day,” said Farooq Kathwari, Chairman, President and CEO. “We are proud to honor the pioneering spirit of our namesake and to celebrate our 91-year heritage as a proud American...

YERINGTON, Nev., June 20, 2023 (GLOBE NEWSWIRE) — Nevada Copper (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) (“Nevada Copper” or the “Company”) provides the results from its 2023 Annual General and Special Meeting of shareholders (the “Meeting”), held today in Toronto. Shareholders holding a total of 419,941,084 common shares of the Company (“Common Shares”) were represented by proxy at the Meeting, representing approximately 58.04% of the total 723,508,700 Common Shares outstanding as of the record date. Shareholders voted in favour of all items of business before the Meeting. Voting DetailsThe following eight nominees were elected as directors of the Company until the next annual shareholder meeting of the Company or until their successors are elected or appointed, with the detailed voting results as follows:Nominee Votes For % For Votes...

NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor and a differentiated, proprietary xB3 ™ platform for delivering therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, today provided an update on its financial condition and operations. As previously disclosed, the termination of the Company’s proposed merger with Midatech Pharma PLC (now Biodexa Pharmaceuticals PLC) (“Biodexa”) in January 2023 left the Company with limited cash and significant liabilities, including a C$350,000 bridge loan from Lind Global Macro Fund,...

New clinical data from COVALENT-111 will be unveiled during a late-breaking poster presentation at ADA’s Scientific Sessions BMF-219, an orally delivered novel covalent menin inhibitor, is designed to regenerate, preserve, and reactivate healthy, insulin-producing beta cells Biomea to hold in-person KOL investor event at the Scientific Sessions in San Diego on Saturday, June 24th at 5:30 pm PT Biomea to hold conference call and webcast on Monday, June 26th at 5:30 am PTREDWOOD CITY, Calif., June 20, 2023 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, today announced that it will present new clinical...

Appointments Reflect Athene’s Transformational Growth and Focus on Regulator and Stakeholder Engagement to Modernize the Industry for Consumers HAMILTON, Bermuda, June 20, 2023 (GLOBE NEWSWIRE) — Athene Holding Ltd. (“Athene”) today announced that Michael Consedine, former Chief Executive Officer of the National Association of Insurance Commissioners (NAIC), will join Athene as Executive Vice President, Head of U.S. Government and Regulatory Relations, effective June 19, 2023. Mr. Consedine will report to John Golden, who has been named Executive Vice President, Global Head of Insurance Regulation for Apollo and Athene. These new roles will advance Athene’s external engagement and growth strategies. In addition, Joe Cohen has been named Executive Vice President and General Counsel for Athene, a role previously held by Mr. Golden....